Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: experimental result in a reliable toxicology laboratory, preceding establishment of guideline and GLP. Documentation is limited.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1969
Report date:
1969

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Deviations:
yes
Remarks:
no notation of adjuvant; challenge exposure was administered via intradermal injection.
GLP compliance:
no
Remarks:
precedes establishment of GLP
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
The described guinea pig sensitisation test similar to OECD 406 was conducted in 1977 before the guidance for the LLNA (OECD429, first adopted in 2002) was available, and before the method was fully established and validated. And since the result of the non-LLNA test is considered to be scientifically valid, the test was not repeated also taking into account exposure and animal welfare considerations.

Test material

Constituent 1
Chemical structure
Reference substance name:
Benzophenone-3,3':4,4'-tetracarboxylic dianhydride
EC Number:
219-348-1
EC Name:
Benzophenone-3,3':4,4'-tetracarboxylic dianhydride
Cas Number:
2421-28-5
Molecular formula:
C17H6O7
IUPAC Name:
5-(1,3-dioxo-1,3-dihydro-2-benzofuran-5-carbonyl)-1,3-dihydro-2-benzofuran-1,3-dione
Test material form:
solid: particulate/powder
Remarks:
migrated information: powder

In vivo test system

Test animals

Species:
guinea pig
Strain:
not specified
Sex:
not specified
Details on test animals and environmental conditions:
no data

Study design: in vivo (non-LLNA)

Induction
Route:
intradermal
Vehicle:
physiological saline
Concentration / amount:
0.4 mg over 8 administrations, 0.1% solution (w/v) of BTDA crystalline powder in normal saline.
Day(s)/duration:
every other day
Adequacy of induction:
not specified
Challenge
No.:
#1
Route:
intradermal
Vehicle:
physiological saline
Concentration / amount:
0.4 mg over 8 administrations, 0.1% solution (w/v) of BTDA crystalline powder in normal saline.
Adequacy of challenge:
not specified
No. of animals per dose:
36
Details on study design:
The study was undertaken with unwashed, commercial grade BTDA, and also with BTDA washed with acetone. Eighteen guinea pigs received intradermal injections (0.05 ml of 0.1% BTDA unwashed w/v in saline, without adjuvant) every other day for 8 injections. They were allowed a rest period of 3 weeks, after which they received a single challenge dose by intradermal injection. The experiment was repeated with BTDA purified by washing in acetone.
Positive control substance(s):
not specified

Results and discussion

In vivo (non-LLNA)

Resultsopen allclose all
Key result
Reading:
1st reading
Group:
other: unwashed BTDA
Dose level:
0.1%
No. with + reactions:
15
Total no. in group:
18
Remarks on result:
positive indication of skin sensitisation
Key result
Reading:
1st reading
Group:
other: acetone-washed BTDA
Dose level:
0.1%
No. with + reactions:
17
Total no. in group:
18
Remarks on result:
positive indication of skin sensitisation

Applicant's summary and conclusion

Interpretation of results:
Category 1A (indication of significant skin sensitising potential) based on GHS criteria
Conclusions:
1,3-Isobenzofurandione, 5,5'-carbonylbis- (BTDA) was purified by washing in acetone, and commercial-grade (unwashed) and purified BTDA was tested in a non-LLNA skin sensitisation test in guinea pigs. Both the unwashed and washed substance were found to be sensitising in the guinea pig.